HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Malcolm Spicer

Malcolm Spicer, Managing Editor – US

Washington, DC
Malcolm Spicer is lead analyst for Pharma intelligence | informa's coverage of the consumer health care products industries. He provides comprehensive and insightful reporting on manufacturing, marketing, regulation, legislation, financial and research news about the nonprescription drug and nutritional product industries. He has worked in this post for 10 years and previously reported for other publications on regulation of the health care industry, on the telecommunications and internet technologies and on the US energy market.

Latest From Malcolm Spicer

50 Years After Pioneering Vaginal Care Branding, Combe Fends Off Similar Competing Trademark

Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

Legal Issues OTC Drugs

Industry Self-Regulation Review Of Claims Smells Unfair To US Essential Oils Marketer DoTerra

“We firmly believe NAD misunderstood the law and applied the wrong legal standard” says Kirk Jowers, doTerra’s corporate relations chief. But the firm “has little recourse but to comply.”

Ad Complaints Enforcement

NIH, CDC Distributing OTC COVID-19 Tests In US Study On Reducing Community Transmission

NIH pays for 2m of Quidel's QuickVue tests in a program it’s conducting with CDC to determine whether frequent self-administered testing helps reduce community transmission of SARS-CoV-2.

Coronavirus COVID-19 OTC Devices

NIH, CDC Distributing OTC COVID-19 Tests In US Study On Reducing Community Transmission

NIH pays for 2 million Quidel QuickVue tests in a program it is conducting with the CDC to determine whether frequent self-administered testing helps reduce community transmission of SARS-CoV-2.

Coronavirus COVID-19 OTC Devices

NIH, CDC Distributing OTC COVID-19 Tests In US Study On Reducing Community Transmission

NIH pays for 2m of Quidel's QuickVue tests in a program it’s conducting with CDC to determine whether frequent self-administered testing helps reduce community transmission of SARS-CoV-2.

Coronavirus COVID-19 OTC Devices

US COVID-19 Claim Warnings Continue; Hi-Tech’s Problems Extend To Undeclared Allergens

Natural Adventure and PYRLess Group are latest firms to learn FDA, FTC continue monitoring the market for claims promoting supplements as COVID-19 treatments. Hi-Tech Pharmaceuticals recalls APS Nutrition Isomorph 28 and iForce Nutrition Mass Gainz due to undeclared allergens.

Dietary Supplements FDA
See All
UsernamePublicRestriction

Register